Stock Financial Ratios, Dividends, Split History

TAP / Molson Coors Brewing Co. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)16,308.94
Enterprise Value ($M)27,354.74
Book Value ($M)13,445.90
Book Value / Share915.21
Price / Book1.23
NCAV ($M)-14,384.00
NCAV / Share-979.07
Price / NCAV-0.07
Share Statistics
Common Shares Outstanding2 2,878,535
Common Shares Outstanding4 195,427,749
Weighted Average Number Of Diluted Shares Outstanding 216,500,000
Common Shares Outstanding 14,691,571
Weighted Average Number Of Shares Outstanding Basic 215,400,000
Common Shares Outstanding3 2,560,568
Scoring Models
Piotroski F-Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.06
Return on Assets (ROA)0.05
Return on Equity (ROE)0.13
Balance Sheet (mrq) ($M)
Quick Ratio0.36
Current Ratio0.52
Income Statement (mra) ($M)
Sales Revenue Goods Net11,002,800,000.00
Sales Revenue Goods Gross13,471,500,000.00
Equity Method Investment Summarized Financial Information Revenue0.00
Operating Income1,725.10
Net Income1,436.40
Earnings Per Share Diluted6.53
Earnings Per Share Basic6.57
Cash Flow Statement (mra) ($M)
Cash From Operations1,866.30
Cash from Investing-538.20
Cash from Financing-538.20
Identifiers and Descriptors
Central Index Key (CIK)24545
Industry Groups
SIC 2082 - Malt Beverages

Split History

Stock splits are used by Molson Coors Brewing Co. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Value On Tap: Premium Brands At A Discount Price With Molson Coors

2018-06-19 seekingalpha
Further volume declines are priced in after a seasonally bad quarter that caused a knee-jerk reaction from investors. (17-0)

Is Molson Coors Brewing Co Stock Set to Rebound 20%?

2018-06-12 investorplace
Investors in Molson Coors Brewing Co (NYSE:TAP) have to be disappointed so far this year. TAP stock is down more than 22% so far in 2018 and more than 27% over the past 12 months. This is compared to the 4.25% year-to-date gain in the SPDR S&P 500 ETF Trust (NYSEARCA:SPY). While Molson now yields 2.6%, investors have to be asking themselves if it’s time to pass on this brew and look for a more refreshing stock. (29-0)

Stocks To Watch: Eyes On Apple's WWDC, SCOTUS And D.C.

2018-06-02 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (932-4)

7 Consumer Goods Stocks That Will Rise Again | InvestorPlace

2018-05-11 investorplace
With the new inflation numbers coming in under expectations, that’s a bullish sign that the Federal Reserve won’t be adding more hikes to interest rates, at least for now. (53-0)

5 Undervalued Large-Cap Stocks For Value Investors - May 2018

2018-05-06 seekingalpha
TAP, CMCSA, LNC, T, and CAH are all rated as suitable for the Defensive Investor and/or the Enterprising Investor following the ModernGraham approach. (82-0)

CUSIP: 60871R209